: Comprehensive parts dedicated to the Esophagus (Part VI), Stomach/Duodenum (Part VII), Pancreas (Part VIII), Biliary Tract (Part IX), and Liver (Part X). Features & Enhanced Learning Tools
With the rise of oncological biologics, the 12th edition includes a groundbreaking new focus on , providing essential guidelines for managing immune-mediated organ damage. 4. Advanced Biological Therapeutics
Dedicated sections cover nutritional principles, assessment, and the management of malnourished patients. You can find these clinical guidelines in the digital version on ClinicalKey .
Sleisenger and Fordtran's Gastrointestinal and Liver Disease 12th edition is a comprehensive and authoritative textbook that continues to set the standard in gastroenterology. The book's updated chapters, new sections, and enhanced illustrations provide a thorough review of the latest advances in gastrointestinal and liver disease. As a result, it is an essential resource for healthcare professionals, researchers, and students seeking to stay up-to-date with the latest developments in the field. Whether you are a gastroenterologist, internal medicine physician, or trainee, this book is a valuable addition to your library, providing practical guidance on the diagnosis, treatment, and management of gastrointestinal and liver disease.
Offers symptom-based pathways for evaluating complex presentations like ambiguous abdominal pain, jaundice, and unexplained diarrhea.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
[ Click here to order the 12th Edition now ] (Link to your store/affiliate page)
What Makes the 12th Edition "Hot": Trending Clinical Updates
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.
Do not wait for the 13th edition (likely 2028-2030). Do not rely on outdated PDFs. Order or access the 12th edition today. Your patients—and your boards—will thank you.
The viral hepatitis section has been completely rewritten. With the global push for Hepatitis C elimination and new data on Hepatitis B reactivation, the 12th edition offers flowcharts that are significantly more aggressive (and effective) than the conservative 11th edition approaches.
Buy the print + eBook bundle. Use the print for deep reading at home; use the app for quick answers on the wards. That combo is universally considered the "hottest" setup.
One of the most significant changes in recent hepatology has been the renaming of non‑alcoholic fatty liver disease (NAFLD) to . The 12th edition provides expanded, state‑of‑the‑art coverage of MASLD, including its pathophysiology, diagnostic criteria, and the expanding array of pharmacologic and lifestyle interventions. With the global epidemic of obesity and metabolic syndrome, this content is more critical than ever.
Edited by IBD expert Dr. David T. Rubin, the text expands dramatically on the management of Crohn's disease and Ulcerative Colitis. It features highly scannable, step-up algorithms mapping out the choice between anti-integrins, anti-IL-23 p19 inhibitors, JAK inhibitors, and S1P receptor modulators. Practitioners gain a clear blueprint for therapeutic drug monitoring and treating acute severe ulcerative colitis in an era of rapid biological sequencing. 5. The Expansion of Microbiome Medicine